Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael F Jarvis

Showing results (11-20 of 123) with videos related to

Pageof 13
Sort By:
Biochemical Pharmacology|November 8, 2020
Adenosine kinase: A key regulator of purinergic physiologyDetlev Boison, Michael F Jarvis
Molecular Pharmacology|December 21, 2012
P2X receptors as drug targetsR Alan North, Michael F Jarvis
Current Opinion in Investigational Drugs (London, England : 2000)|July 5, 2008
Homomeric and heteromeric P2X3 receptors in peripheral sensory neuronsJill-Desiree Brederson, Michael F Jarvis
Biochemical Pharmacology|January 15, 2018
EditorialMichael F Jarvis, S J Enna
Neuropharmacology|July 29, 2008
ATP-gated P2X cation-channelsMichael F Jarvis, Baljit S Khakh
British Journal of Pharmacology|March 22, 2002
Antagonism of P2X3-containing channels: commentary on Spelta et alMichael F Jarvis, Edward C Burgard
Current Pharmaceutical Design|May 16, 2009
Neuropathic pain: models and mechanismsMichael F Jarvis, Janel M Boyce-Rustay
Pharmacology Research & Perspectives|January 24, 2023
Pharmacology Research & Perspectives: A Decade of ProgressMichael F Jarvis, Emily Davies, Jennifer H Martin
Journal of Medicinal Chemistry|September 6, 2002
Purine and pyrimidine (P2) receptors as drug targetsKenneth A Jacobson, Michael F Jarvis, Michael Williams
Purinergic Signalling|November 17, 2011
P2X receptor antagonists for pain management: examination of binding and physicochemical propertiesRebecca J Gum, Brian Wakefield, Michael F Jarvis
Pageof 13

Showing results (11-20 of 123) with videos related to

Sort By:
Pageof 13
Biochemical Pharmacology|November 8, 2020
Adenosine kinase: A key regulator of purinergic physiologyDetlev Boison, Michael F Jarvis
Molecular Pharmacology|December 21, 2012
P2X receptors as drug targetsR Alan North, Michael F Jarvis
Current Opinion in Investigational Drugs (London, England : 2000)|July 5, 2008
Homomeric and heteromeric P2X3 receptors in peripheral sensory neuronsJill-Desiree Brederson, Michael F Jarvis
Biochemical Pharmacology|January 15, 2018
EditorialMichael F Jarvis, S J Enna
Neuropharmacology|July 29, 2008
ATP-gated P2X cation-channelsMichael F Jarvis, Baljit S Khakh
British Journal of Pharmacology|March 22, 2002
Antagonism of P2X3-containing channels: commentary on Spelta et alMichael F Jarvis, Edward C Burgard
Current Pharmaceutical Design|May 16, 2009
Neuropathic pain: models and mechanismsMichael F Jarvis, Janel M Boyce-Rustay
Pharmacology Research & Perspectives|January 24, 2023
Pharmacology Research & Perspectives: A Decade of ProgressMichael F Jarvis, Emily Davies, Jennifer H Martin
Journal of Medicinal Chemistry|September 6, 2002
Purine and pyrimidine (P2) receptors as drug targetsKenneth A Jacobson, Michael F Jarvis, Michael Williams
Purinergic Signalling|November 17, 2011
P2X receptor antagonists for pain management: examination of binding and physicochemical propertiesRebecca J Gum, Brian Wakefield, Michael F Jarvis
Pageof 13